BRUSSELS, April 22 (Reuters) - The European Commission said
on Thursday it would not take up an option to buy 100 million
additional doses of AstraZeneca's COVID-19 vaccine which
is included in the current supply contract the EU has with the
company.
A spokesman told a news conference that the deadline to
exercise the option had already expired and the EU did not plan
to take it up, confirming a Reuters report from Wednesday
.
The Commission has ordered 300 million doses from
AstraZeneca as part of a contract that included 400 million
doses, of which 100 million was optional.
(Reporting by Francesco Guarascio @fraguarascio
Editing by Gareth Jones)